when is retatrutide coming out FDA Approval Status 2026: Everything We Know So Far Retatrutide, an experimental weight-loss drug,

Ensure your clinic prescribes scientifically-validated branded medications over compounded or unknown alternatives

Stained slides were scanned using a Leica SCN400 slide scanner

If you do experience mood shifts, they typically resolve within weeks as your body adapts

15 This divergence between small molecule (5 years) and biologic (12 years) exclusivity has created a strategic incentive for pharmaceutical companies to prioritize biological development, particularly in light of new pricing negotiation frameworks that treat the two modalities differently

FDA Approved: No Generic Name: Retatrutide Manufacturer: Eli Lilly and Company Intended Use: Treatment of Obesity and Overweight Retatrutide is a next-generation, triple-hormone receptor agonist currently under development for the treatment of obesity